Global Antibody Drug Conjugate (ADC) Drug Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Antibody Drug Conjugate (ADC) Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Antibody Drug Conjugate (ADC) Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Drug Conjugate (ADC) Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Antibody Drug Conjugate (ADC) Drug, covering the supply chain analysis, impact assessment to the Antibody Drug Conjugate (ADC) Drug market size growth rate in several scenarios, and the measures to be undertaken by Antibody Drug Conjugate (ADC) Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Mmunomedics Technology
Immunogen Technology
Seattle Genetics Technology
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Biotechnology Companies
Specialized Cancer Centers
Biopharmaceutical Companies
Academic Research Institutes
Hospitals
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Oxford Bio Therapeutics
Heidelberg Pharma
Synthon
Bayer HealthCare
Millennium Pharmaceuticals
Progenics Pharmaceuticals
Roche Holding AG
Pfizer
Seattle Genetics
Concortis Bio therapeutics
Agensys
ImmunoGen
Genentech
Mersana Therapeutics
Celldex Therapeutics
AbbVie Inc
Genmab
Immunomedics
Astellas Pharma/Agensys
Sanofi
Novartis
Eli Lilly
Amgen
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Antibody Drug Conjugate (ADC) Drug market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Antibody Drug Conjugate (ADC) Drug market by identifying its various subsegments.
Focuses on the key global Antibody Drug Conjugate (ADC) Drug players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antibody Drug Conjugate (ADC) Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Antibody Drug Conjugate (ADC) Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody Drug Conjugate (ADC) Drug Market Size 2015-2025
2.1.2 Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region
2.2 Antibody Drug Conjugate (ADC) Drug Segment by Type
2.2.1 Mmunomedics Technology
2.2.2 Mmunomedics Technology
2.2.3 Seattle Genetics Technology
2.2.4 Others
2.3 Antibody Drug Conjugate (ADC) Drug Market Size by Type
2.3.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2015-2020)
2.3.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Type (2015-2020)
2.4 Antibody Drug Conjugate (ADC) Drug Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Specialized Cancer Centers
2.4.3 Biopharmaceutical Companies
2.4.4 Academic Research Institutes
2.4.5 Hospitals
2.4.6 Others
2.5 Antibody Drug Conjugate (ADC) Drug Market Size by Application
2.5.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2015-2020)
2.5.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate by Application (2015-2020)
3 Global Antibody Drug Conjugate (ADC) Drug by Players
3.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Players
3.1.1 Global Antibody Drug Conjugate (ADC) Drug Market Size by Players (2018-2020)
3.1.2 Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Players (2018-2020)
3.2 Global Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antibody Drug Conjugate (ADC) Drug by Regions
4.1 Antibody Drug Conjugate (ADC) Drug Market Size by Regions
4.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size Growth
4.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size Growth
4.4 Europe Antibody Drug Conjugate (ADC) Drug Market Size Growth
4.5 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Growth
5 Americas
5.1 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Countries
5.2 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type
5.3 Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Regions
6.2 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type
6.3 APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Antibody Drug Conjugate (ADC) Drug by Countries
7.2 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type
7.3 Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Antibody Drug Conjugate (ADC) Drug by Countries
8.2 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type
8.3 Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Antibody Drug Conjugate (ADC) Drug Market Forecast
10.1 Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast (2021-2025)
10.2 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions
10.2.1 Global Antibody Drug Conjugate (ADC) Drug Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Antibody Drug Conjugate (ADC) Drug Forecast by Type
10.8 Global Antibody Drug Conjugate (ADC) Drug Forecast by Application
11 Key Players Analysis
11.1 Oxford Bio Therapeutics
11.1.1 Company Details
11.1.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.1.3 Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Oxford Bio Therapeutics News
11.2 Heidelberg Pharma
11.2.1 Company Details
11.2.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.2.3 Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Heidelberg Pharma News
11.3 Synthon
11.3.1 Company Details
11.3.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.3.3 Synthon Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Synthon News
11.4 Bayer HealthCare
11.4.1 Company Details
11.4.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.4.3 Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Bayer HealthCare News
11.5 Millennium Pharmaceuticals
11.5.1 Company Details
11.5.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.5.3 Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Millennium Pharmaceuticals News
11.6 Progenics Pharmaceuticals
11.6.1 Company Details
11.6.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.6.3 Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Progenics Pharmaceuticals News
11.7 Roche Holding AG
11.7.1 Company Details
11.7.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.7.3 Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Roche Holding AG News
11.8 Pfizer
11.8.1 Company Details
11.8.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.8.3 Pfizer Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Pfizer News
11.9 Seattle Genetics
11.9.1 Company Details
11.9.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.9.3 Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Seattle Genetics News
11.10 Concortis Bio therapeutics
11.10.1 Company Details
11.10.2 Antibody Drug Conjugate (ADC) Drug Product Offered
11.10.3 Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Concortis Bio therapeutics News
11.11 Agensys
11.12 ImmunoGen
11.13 Genentech
11.14 Mersana Therapeutics
11.15 Celldex Therapeutics
11.16 AbbVie Inc
11.17 Genmab
11.18 Immunomedics
11.19 Astellas Pharma/Agensys
11.20 Sanofi
11.21 Novartis
11.22 Eli Lilly
11.23 Amgen
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Antibody Drug Conjugate (ADC) Drug Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Mmunomedics Technology
Table 5. Major Players of Immunogen Technology
Table 6. Major Players of Seattle Genetics Technology
Table 7. Major Players of Others
Table 8. Antibody Drug Conjugate (ADC) Drug Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2015-2020)
Table 10. Global Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2015-2020)
Table 12. Global Antibody Drug Conjugate (ADC) Drug Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Antibody Drug Conjugate (ADC) Drug Revenue Market Share by Players (2018-2020)
Table 14. Global Antibody Drug Conjugate (ADC) Drug Key Players Head office and Products Offered
Table 15. Antibody Drug Conjugate (ADC) Drug Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antibody Drug Conjugate (ADC) Drug Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions 2015-2020
Table 20. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Countries (2015-2020)
Table 22. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2015-2020)
Table 24. Americas Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2015-2020)
Table 26. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions (2015-2020)
Table 28. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2015-2020)
Table 30. APAC Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2015-2020)
Table 32. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Countries (2015-2020)
Table 34. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2015-2020)
Table 36. Europe Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Antibody Drug Conjugate (ADC) Drug
Table 45. Key Application and Potential Industries of Antibody Drug Conjugate (ADC) Drug
Table 46. Key Challenges of Antibody Drug Conjugate (ADC) Drug
Table 47. Key Trends of Antibody Drug Conjugate (ADC) Drug
Table 48. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Regions
Table 50. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Antibody Drug Conjugate (ADC) Drug Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share Forecast by Application (2021-2025)
Table 54. Oxford Bio Therapeutics Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 55. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 56. Oxford Bio Therapeutics Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 57. Oxford Bio Therapeutics Main Business
Table 58. Oxford Bio Therapeutics Latest Developments
Table 59. Heidelberg Pharma Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 60. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Product Offered
Table 61. Heidelberg Pharma Main Business
Table 62. Heidelberg Pharma Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 63. Heidelberg Pharma Latest Developments
Table 64. Synthon Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 65. Synthon Antibody Drug Conjugate (ADC) Drug Product Offered
Table 66. Synthon Main Business
Table 67. Synthon Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 68. Synthon Latest Developments
Table 69. Bayer HealthCare Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 70. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Product Offered
Table 71. Bayer HealthCare Main Business
Table 72. Bayer HealthCare Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 73. Bayer HealthCare Latest Developments
Table 74. Millennium Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 75. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 76. Millennium Pharmaceuticals Main Business
Table 77. Millennium Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 78. Millennium Pharmaceuticals Latest Developments
Table 79. Progenics Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 80. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Product Offered
Table 81. Progenics Pharmaceuticals Main Business
Table 82. Progenics Pharmaceuticals Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 83. Progenics Pharmaceuticals Latest Developments
Table 84. Roche Holding AG Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 85. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Product Offered
Table 86. Roche Holding AG Main Business
Table 87. Roche Holding AG Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 88. Roche Holding AG Latest Developments
Table 89. Pfizer Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 90. Pfizer Antibody Drug Conjugate (ADC) Drug Product Offered
Table 91. Pfizer Main Business
Table 92. Pfizer Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 93. Pfizer Latest Developments
Table 94. Seattle Genetics Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 95. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 96. Seattle Genetics Main Business
Table 97. Seattle Genetics Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 98. Seattle Genetics Latest Developments
Table 99. Concortis Bio therapeutics Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 100. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Product Offered
Table 101. Concortis Bio therapeutics Main Business
Table 102. Concortis Bio therapeutics Antibody Drug Conjugate (ADC) Drug Revenue and Gross Margin (2018-2020E)
Table 103. Concortis Bio therapeutics Latest Developments
Table 104. Agensys Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 105. ImmunoGen Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 106. Genentech Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 107. Mersana Therapeutics Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 108. Celldex Therapeutics Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 109. AbbVie Inc Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 110. Genmab Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 111. Immunomedics Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 112. Astellas Pharma/Agensys Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 113. Sanofi Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 114. Novartis Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 115. Eli Lilly Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
Table 116. Amgen Details, Company Total Revenue (in $ million), Head Office, Antibody Drug Conjugate (ADC) Drug Major Market Areas and Its Competitors
List of Figures
Figure 1. Antibody Drug Conjugate (ADC) Drug Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Antibody Drug Conjugate (ADC) Drug Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type (2015-2020)
Figure 5. Global by Technology Market Size Growth Rate
Figure 6. Global by Product Type Market Size Growth Rate
Figure 7. Antibody Drug Conjugate (ADC) Drug in Biotechnology Companies
Figure 8. Global Antibody Drug Conjugate (ADC) Drug Market: Biotechnology Companies (2015-2020) ($ Millions)
Figure 9. Antibody Drug Conjugate (ADC) Drug in Specialized Cancer Centers
Figure 10. Global Antibody Drug Conjugate (ADC) Drug Market: Specialized Cancer Centers (2015-2020) ($ Millions)
Figure 11. Antibody Drug Conjugate (ADC) Drug in Biopharmaceutical Companies
Figure 12. Global Antibody Drug Conjugate (ADC) Drug Market: Biopharmaceutical Companies (2015-2020) ($ Millions)
Figure 13. Global Biopharmaceutical Companies YoY Growth ($ Millions)
Figure 14. Antibody Drug Conjugate (ADC) Drug in Academic Research Institutes
Figure 15. Global Antibody Drug Conjugate (ADC) Drug Market: Academic Research Institutes (2015-2020) ($ Millions)
Figure 16. Global Academic Research Institutes YoY Growth ($ Millions)
Figure 17. Antibody Drug Conjugate (ADC) Drug in Hospitals
Figure 18. Global Antibody Drug Conjugate (ADC) Drug Market: Hospitals (2015-2020) ($ Millions)
Figure 19. Global Hospitals YoY Growth ($ Millions)
Figure 20. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2019
Figure 21. Global Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions 2015-2020
Figure 22. Americas Antibody Drug Conjugate (ADC) Drug Market Size 2015-2020 ($ Millions)
Figure 23. APAC Antibody Drug Conjugate (ADC) Drug Market Size 2015-2020 ($ Millions)
Figure 24. Europe Antibody Drug Conjugate (ADC) Drug Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size 2015-2020 ($ Millions)
Figure 26. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Countries in 2019
Figure 27. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2019
Figure 28. Americas Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2019
Figure 29. United States Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Regions in 2019
Figure 33. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2019
Figure 34. APAC Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2019
Figure 35. China Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Countries in 2019
Figure 42. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2019
Figure 43. Europe Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2019
Figure 44. Germany Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size Market Share by Application in 2019
Figure 53. Egypt Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Antibody Drug Conjugate (ADC) Drug Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Antibody Drug Conjugate (ADC) Drug arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 60. APAC Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 61. Europe Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 63. United States Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 64. Canada Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 67. China Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 68. Japan Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 69. Korea Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 71. India Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 72. Australia Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 73. Germany Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 74. France Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 75. UK Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 76. Italy Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 77. Russia Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 78. Spain Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 81. Israel Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Antibody Drug Conjugate (ADC) Drug Market Size 2021-2025 ($ Millions)
